Skip to main content
UniHealth

Doctor search

Huy Vu Nguyen, MD

Ophthalmology · West Covina

NPI 1497140446

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Joseph L Lin MD Inc · 3 clinicians in this group

Looking this up.

Hospitals listed: Pomona Valley Hospital Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nguyen’s office at (626) 653-9444 to ask if they take your plan before you enroll.

California Medical Board record

Licence A161710 · Current

Licensed to practise in California · since 2019 · expires 2027-04-30 · Columbia University College of Physicians and Surgeons.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Pomona Valley Hospital Medical CenterPomona, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Pomona Valley Hospital Medical CenterPatients rate it 2 of 5 · 68% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.64 (0.33 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.398, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.389, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.155, Oct 2024 – Sep 2025
See every measure and the patient survey for Pomona Valley Hospital Medical Center

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Pomona Valley Hospital Medical Center
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.64 (0.33 to 0.96)BetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.398BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.389BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.155BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.85 (0 to 1.84) · 1,069 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths169.52 (120.62 to 218.41) · 65 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.7 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 51 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.5 · 110 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.2 · 369 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.5 · 190 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.7 · 583 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.2 · 3,744 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.15 (0 to 0.35) · 5,235 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.42) · 5,161 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.2 (1.1 to 5.3) · 996 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.55 (0 to 3.22) · 180 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.88 (0.32 to 3.44) · 911 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths4.99 (0 to 12.42) · 189 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.25 (0.34 to 8.16) · 172 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.6 (0.14 to 3.05) · 196 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.1 (0 to 0.65) · 4,157 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.6 · 64 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.953No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.438No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.9 · 278 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.8 · 982 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-1.1 · 128 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-51.4 · 454 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-29.1 · 219 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.1 · 453 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.2 to 7.6) · 74 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.3 (9.5 to 18.1) · 74 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 57 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.9 · 97 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.5 · 137 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.5 (10.1 to 18) · 319 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.3) · 199 casesNo differentJan 2024 – Dec 2024

What patients said (2,021 patients answered, 13% of those asked)

Patient survey stars by topic at Pomona Valley Hospital Medical Center
Cleanliness3
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital3
Share of patients giving the best answer at Pomona Valley Hospital Medical Center
Room was "always" clean68%
Nurses "always" communicated well74%
Doctors "always" communicated well73%
Staff "always" explained57%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge80%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully71%
Doctors "always" treated them with courtesy and respect79%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications71%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital68%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$628,994

Medicare paid this office $628,994 for 404 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, faricimab-svoa, 0.1 mg41$300,848None
Injection, aflibercept, 1 mg11$60,593None
Established patient complete exam of visual system305$59,694$105
Injection of drug into eye95$39,207$112
Imaging of retina349$28,712$35
See all 12 services
Every Original Medicare service billed
Injection, faricimab-svoa, 0.1 mg41$300,848None
Injection, aflibercept, 1 mg11$60,593None
Established patient complete exam of visual system305$59,694$105
Injection of drug into eye95$39,207$112
Imaging of retina349$28,712$35
Established patient problem focused exam of visual system120$22,939$81
Exam of retinal blood vessels using a special camera after injection of a dye103$20,580$151
New patient visit (45+ min)154$18,369$119
Injection, bevacizumab, 10 mg63$9,162None
Extended exam of the back part of the eye with retinal drawing246$7,833$20
Photography of the retina104$4,041$29
2d ultrasound scan of eye tissue and structures23$2,355$44

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

404 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 13% · Women 56% · Also on Medicaid 31% · Health risk score 1.58. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 73% · Diabetes 44% · Coronary heart disease 29% · Chronic kidney disease 26% · Heart failure 18% · Depression 15% · Cancer 13% · Atrial fibrillation 13% · COPD 12% · Stroke 9% · Dementia 6%.

The office billed $1,422,269, Medicare allowed $810,520 and paid $628,994; for 14,374 services of 38 kinds; $386,901 of it was for drugs given in the office and $242,092 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202440414,374741.58$1,422,269$628,994
20233484,565731.54$905,953$363,984
20222051,973731.33$545,229$214,545
2021115278761.27$110,541$22,871
2020105139761.57$144,465$9,771
20196382731.59$96,501$5,822

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg24$120,023None
Injection, faricimab-svoa, 0.1 mg14$51,981None
Established patient complete exam of visual system223$45,829$102
Injection of drug into eye68$25,406$105
New patient visit (45+ min)201$25,002$124
Imaging of retina292$20,706$34
Exam of retinal blood vessels using a special camera after injection of a dye93$14,422$124
Extended exam of the back part of the eye with retinal drawing272$9,994$20
Established patient problem focused exam of visual system54$7,855$78
Injection, bevacizumab, 10 mg48$7,367None
Photocoagulation treatment to prevent detachment of retina14$3,643$214
Photography of the retina94$3,259$28
2d ultrasound scan of eye tissue and structures27$1,872$43

2022: 11 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg18$78,837None
Established patient complete exam of visual system109$29,569$108
Injection of drug into eye51$20,183$113
New patient visit (45+ min)150$18,331$122
Exam of retinal blood vessels using a special camera after injection of a dye91$13,992$115
Imaging of retina158$12,737$35
Injection, bevacizumab, 10 mg47$6,547None
Extended exam of the back part of the eye with retinal drawing146$6,448$21
Established patient problem focused exam of visual system42$6,000$76
Photography of the retina91$3,377$28
2d ultrasound scan of eye tissue and structures17$976$42

2021: 9 services

Original Medicare services billed in 2021
New patient visit (45+ min)32$4,373$137
Exam of retinal blood vessels using a special camera after injection of a dye28$2,608$90
Injection of drug into eye12$2,059$108
Short return visit (20+ min)44$2,041$46
Established patient complete exam of visual system12$1,512$116
Imaging of retina35$1,264$31
Injection, bevacizumab, 10 mg11$957None
Photography of the retina21$685$33
Extended exam of the back part of the eye with retinal drawing21$488$22

2020: 3 services

Original Medicare services billed in 2020
Short return visit (20+ min)55$2,497$42
Exam of retinal blood vessels using a special camera after injection of a dye15$733$41
Imaging of retina17$439$23

2019: 1 service

Original Medicare services billed in 2019
Short return visit (20+ min)32$1,556$46

Medicaid work

$146,951 in 2024

Medicaid paid $146,951 for 3,063 billed services this clinician did in 2024, up to 77 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)431$68,862
Injection, bevacizumab, 10 mg338$18,459
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina718$14,189
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI239$11,844
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST452$10,535
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient355$8,491
New patient visit (45+ min)139$6,420
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT238$6,207
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral153$1,943
Medicaid work by year
20243,063977$146,951
20232,944962$189,825
20222,142961$135,669
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)357$80,029
Injection, bevacizumab, 10 mg278$19,558
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST480$18,236
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina642$18,035
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI180$14,115
New patient visit (45+ min)199$11,363
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient222$10,355
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral401$10,304
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT185$7,831

2022

Largest Medicaid services in 2022
Intravitreal injection of a pharmacologic agent (separate procedure)186$44,612
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST296$16,669
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina479$16,561
New patient visit (45+ min)245$15,844
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral384$12,152
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI147$10,267
Injection, bevacizumab, 10 mg145$7,852
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT151$6,246
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient109$5,465

Drugs they prescribed that Part D paid

$17,583

Pharmacies billed $17,583 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 418) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

253 generic and 165 brand-name prescriptions · $17,583 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Brimonidine40$2,499$62
Prednisolone Acetate82$2,297$28
Dorzolamide-Timolol62$1,024$17
Latanoprost107$734$7
Ketorolac Tromethamine21$658$31
See all 8 drugs
Every Part D drug this clinician prescribed
Brimonidine40$2,499$62
Prednisolone Acetate82$2,297$28
Dorzolamide-Timolol62$1,024$17
Latanoprost107$734$7
Ketorolac Tromethamine21$658$31
Moxifloxacin15$366$24
Dorzolamide12$233$19
Timolol Maleate17$136$8

Year by year

Part D prescribing by year
20244181160% (0)39%$17,583
2023318780% (0)36%$17,470
2022186610% (0)35%$8,457
202174390% (0)50%$8,485
202022082None53%$41,291
2019326960% (0)48%$114,869
201816172None50%$9,957
20177350None34%$4,523
20168154NoneNone$4,677
201535170% (0)None$1,983

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate47$1,661$35
Dorzolamide-Timolol60$1,606$27
Brimonidine28$1,552$55
Latanoprost74$1,126$15
Ketorolac Tromethamine22$556$25
Dorzolamide18$372$21

2022: 5 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate43$1,600$37
Dorzolamide-Timolol20$699$35
Latanoprost39$652$17
Dorzolamide27$605$22
Brimonidine11$163$15

2021: 2 drugs

Part D drugs prescribed in 2021
Prednisolone Acetate12$536$45
Brimonidine14$109$8

2020: 8 drugs

Part D drugs prescribed in 2020
Timoptic Ocudose11$5,714$519
Prednisolone Acetate31$1,579$51
Timolol Maleate11$625$57
Latanoprost28$591$21
Dorzolamide-Timolol11$512$47
Moxifloxacin12$340$28
Prednisone14$204$15
Brimonidine13$201$15

2019: 6 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate51$3,709$73
Moxifloxacin52$2,738$53
Ketorolac Tromethamine44$1,300$30
Dorzolamide-Timolol28$1,069$38
Latanoprost42$889$21
Brimonidine13$871$67

2018: 5 drugs

Part D drugs prescribed in 2018
Ilevro13$4,160$320
Prednisolone Acetate44$1,538$35
Moxifloxacin16$671$42
Ketorolac Tromethamine17$366$22
Erythromycin19$223$12

Money from drug and device companies

$282 in 2025

Industry payments by year
2025310None$282
2024413None$395
202334None$122
202255None$210
202146None$430
202012None$27
2019310None$1,763

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Astellas Pharma USIzervay$172
6 payments
  • Meals for Izervay · 2025-10-24 · $33
  • Meals for Izervay · 2025-09-26 · $33
  • Meals for Izervay · 2025-08-22 · $29
  • Meals for Izervay · 2025-07-11 · $29
  • Meals for Izervay · 2025-01-23 · $30
  • Meals for Izervay · 2025-01-15 · $18
Genentech USAVabysmo$84
3 payments
  • Meals for Vabysmo · 2025-10-31 · $26
  • Meals for Vabysmo · 2025-08-07 · $38
  • Meals for Vabysmo · 2025-07-17 · $20
ANI PharmaceuticalsIluvien$26
1 payment
  • Meals for Iluvien · 2025-10-16 · $26
See all 10 published payments
Every published payment
Genentech USAMeals · 2025-10-31Vabysmo$26
Astellas Pharma USMeals · 2025-10-24Izervay$33
ANI PharmaceuticalsMeals · 2025-10-16Iluvien$26
Astellas Pharma USMeals · 2025-09-26Izervay$33
Astellas Pharma USMeals · 2025-08-22Izervay$29
Genentech USAMeals · 2025-08-07Vabysmo$38
Genentech USAMeals · 2025-07-17Vabysmo$20
Astellas Pharma USMeals · 2025-07-11Izervay$29
Astellas Pharma USMeals · 2025-01-23Izervay$30
Astellas Pharma USMeals · 2025-01-15Izervay$18
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $395

Payments by company in 2024
Astellas Pharma USIzervay$255
7 payments
  • Meals for Izervay · 2024-11-13 · $23
  • Meals for Izervay · 2024-10-11 · $16
  • Meals for Izervay · 2024-09-26 · $125
  • Meals for Izervay · 2024-08-30 · $25
  • Meals for Izervay · 2024-08-29 · $9
  • Meals for Izervay · 2024-07-19 · $23
  • Meals for Izervay · 2024-03-14 · $34
Genentech USAVabysmo$101
4 payments
  • Meals for Vabysmo · 2024-12-05 · $25
  • Meals for Vabysmo · 2024-09-17 · $26
  • Meals for Vabysmo · 2024-04-11 · $31
  • Meals for Vabysmo · 2024-01-19 · $19
Alimera SciencesYutiq$22
1 payment
  • Meals for Yutiq · 2024-04-24 · $22
BiogenByooviz$17
1 payment
  • Meals for Byooviz · 2024-05-23 · $17

2023: $122

Payments by company in 2023
Genentech USAVabysmo$61
2 payments
  • Meals for Vabysmo · 2023-11-09 · $29
  • Meals for Vabysmo · 2023-05-06 · $31
Apellis PharmaceuticalsSyfovre$31
1 payment
  • Meals for Syfovre · 2023-05-24 · $31
Astellas Pharma USNone$30
1 payment
  • Meals · 2023-09-01 · $30

2022: $210

Payments by company in 2022
Horizon Therapeutics plcTepezza$73
1 payment
  • Meals for Tepezza · 2022-04-28 · $73
Alimera SciencesIluvien$62
1 payment
  • Meals for Iluvien · 2022-06-22 · $62
Regeneron Healthcare SolutionsEylea$32
1 payment
  • Meals for Eylea · 2022-09-15 · $32
Genentech USASusvimo$26
1 payment
  • Meals for Susvimo · 2022-08-11 · $26
AbbvieOzurdex$18
1 payment
  • Meals for Ozurdex · 2022-07-13 · $18

2021: $430

Payments by company in 2021
Alimera SciencesIluvien$160
2 payments
  • Meals for Iluvien · 2021-09-16 · $78
  • Meals for Iluvien · 2021-05-26 · $82
AllerganOzurdex$139
2 payments
  • Meals · 2021-10-20 · $24
  • Meals for Ozurdex · 2021-06-17 · $115
Regeneron Healthcare SolutionsEylea$115
1 payment
  • Meals for Eylea · 2021-06-24 · $115
AbbVieUbrelvy$15
1 payment
  • Meals for Ubrelvy · 2021-01-07 · $15

2020: $27

Payments by company in 2020
AllerganUbrelvy$27
2 payments
  • Meals for Ubrelvy · 2020-12-10 · $13
  • Meals for Ubrelvy · 2020-06-18 · $14

2019: $1,763

Payments by company in 2019
Alcon VisionDailies$1,396
7 payments
  • Meals · 2019-11-22 · $239
  • Travel · 2019-11-22 · $194
  • Travel · 2019-11-22 · $80
  • Travel for Dailies · 2019-11-22 · $411
  • Meals · 2019-05-19 · $434
  • Meals for Constellation · 2019-05-03 · $19
  • Meals for Constellation · 2019-02-16 · $19
Alimera SciencesIluvien$250
2 payments
  • Meals for Iluvien · 2019-09-23 · $125
  • Meals for Iluvien · 2019-09-23 · $125
Aerie PharmaceuticalsRhopressa$117
1 payment
  • Meals for Rhopressa · 2019-08-29 · $117

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1497140446
Licence
CA A161710California A161710: Current · expires 2027-04-30
Trained
Columbia University College of Physicians and Surgeons, 2015
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2015-04-06
NPI last updated
2019-07-02

This is when the NPI record was last certified, not a medical board exam.